Ushbu ishga iqtibos qilgan ishlar

3 ta ish

Ish: Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.

1. Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

   Nigora Rasulova, Vladimir Lyubshin, Д. Т. Арыбжанов +3

   MaqolaOAOchiq kirishRadiopharmaceutical Chemistry and ApplicationsWorld Journal of Nuclear Medicine20130 iqtibos

   ABIABI:AkademIndex/2013.article.000100

2. Effectiveness of Bone Metastases Treatment by Sm–153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience

   Nigora Rasulova, Vladimir Lyubshin, Д. Т. Арыбжанов +2

   MaqolaOAOchiq kirishRadiopharmaceutical Chemistry and ApplicationsWorld Journal of Nuclear Medicine20130 iqtibos

   ABIABI:AkademIndex/2013.article.000148

3. Role of samarium-153-ethylene diamine tetramethylene phosphonate radionuclide bone pain palliation in patients with metastatic bone disease

   R Narayan, Manthri RG, K Thiruvengadaswamy +3

   MaqolaOAOchiq kirish20170 iqtibos

   ABIABI:AkademIndex/2017.article.001203